Solventum Corporation (SOLV)

$85.26 +0.01 (0.01%)
Market Cap 14.85B
Revenue (ttm) 8.25B
Net Income (ttm) 478.00M
EPS (ttm) N/A
PE Ratio 14.40
Forward PE 14.18
Profit Margin 5.79%
Debt to Equity Ratio 1.03
Volume 929,600
Avg Vol 1,058,534
Day's Range N/A - N/A
Shares Out 173.45M
Stochastic %K 71%
Beta 0.26
Analysts Sell
Price Target $84.70

Company Profile

Solventum Corporation, a healthcare company, develops, manufactures, and commercializes a portfolio of solutions to address critical customer and patient needs in the United States and internationally. It operates in four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment offers solutions for negative pressure wound therapy, advanced wound dressings, advanced skin care, I.V. site management, sterilization assurance, temperature m...

Industry: Medical Instruments & Supplies
Sector: Healthcare
Phone: 651 733 1110
Address:
3M Center, Building 275-6W-20 2510 Conway Avenue East St. Paul, Maplewood, United States
Iightning
Iightning Dec. 5 at 1:59 AM
1ightning® Premium Options Alert (Actionable) Ticker: $SOLV Contract: Dec 19 $85C Entry: 2.08 Exit: 2.78 Return: +34.17% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
Iightning
Iightning Dec. 4 at 8:31 PM
1ightning® Premium Options Alert (Actionable) Ticker: $SOLV Contract: Dec 19 $85C Entry: 2.08 Exit: 2.78 Return: +34.17% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
AtomicAIerts
AtomicAIerts Dec. 4 at 5:05 PM
$SOLV AtomicAlerts® Scalp Alert Direction: SHORT Entry: $85.06 TP1: $84.36 | TP2: $83.66 | TP3: $82.96 Stop Loss: $85.66 EMA9: 85.15 | EMA21: 85.17 RSI14: 43.24 | VWAP: 85.18 Paid Alerts: https://atomicalerts.com
0 · Reply
AtomicAIerts
AtomicAIerts Dec. 4 at 3:31 PM
$SOLV AtomicAlerts® Scalp Alert Direction: LONG Entry: $85.19 TP1: $85.89 | TP2: $86.59 | TP3: $87.29 Stop Loss: $84.59 EMA9: 85.18 | EMA21: 85.12 RSI14: 54.19 | VWAP: 85.17 Paid Alerts: https://atomicalerts.com
0 · Reply
AtomicAIerts
AtomicAIerts Dec. 4 at 1:54 PM
$SOLV AtomicAlerts® Scalp Alert Direction: SHORT Entry: $85.25 TP1: $84.55 | TP2: $83.85 | TP3: $83.15 Stop Loss: $85.85 EMA9: 85.25 | EMA21: 85.23 RSI14: 47.06 | VWAP: 85.92 Paid Alerts: https://atomicalerts.com
0 · Reply
AtomicAIerts
AtomicAIerts Dec. 4 at 12:20 PM
$SOLV AtomicAlerts® Scalp Alert Direction: SHORT Entry: $85.25 TP1: $84.55 | TP2: $83.85 | TP3: $83.15 Stop Loss: $85.85 EMA9: 85.25 | EMA21: 85.23 RSI14: 47.06 | VWAP: 85.92 Paid Alerts: https://atomicalerts.com
0 · Reply
Iightning
Iightning Dec. 4 at 4:14 AM
1ightning® Premium Options Alert (Actionable) Ticker: $SOLV Contract: Dec 19 $85C Entry: 1.97 Exit: 2.53 Return: +28.29% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 3 at 3:40 PM
$SOLV Current Stock Price: $85.26 Contracts to trade: $85 SOLV Dec 19 2025 Call Entry: $2.00 Exit: $3.57 ROI: 79% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Iightning
Iightning Dec. 3 at 8:45 AM
1ightning® Premium Options Alert (Actionable) Ticker: $SOLV Contract: Dec 19 $50C Entry: 24.25 Exit: 34.70 Return: +43.11% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
JarvisFlow
JarvisFlow Dec. 2 at 11:05 AM
BTIG has adjusted their stance on Solventum ( $SOLV ), setting the rating to Buy with a target price of 100.
0 · Reply
Latest News on SOLV
Solventum Corporation (SOLV) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Dec 2, 2025, 12:23 PM EST - 2 days ago

Solventum Corporation (SOLV) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Solventum to Participate in the 2025 Piper Sandler Healthcare Conference

Nov 25, 2025, 4:05 PM EST - 9 days ago

Solventum to Participate in the 2025 Piper Sandler Healthcare Conference

Solventum Announces $1 Billion Share Repurchase Program

Nov 20, 2025, 9:00 AM EST - 14 days ago

Solventum Announces $1 Billion Share Repurchase Program

Solventum Announces Agreement to Acquire Acera Surgical

Nov 20, 2025, 9:00 AM EST - 14 days ago

Solventum Announces Agreement to Acquire Acera Surgical

Solventum Corporation (SOLV) Presents at Stifel 2025 Healthcare Conference Transcript

Nov 12, 2025, 1:51 PM EST - 22 days ago

Solventum Corporation (SOLV) Presents at Stifel 2025 Healthcare Conference Transcript

Solventum: A Mixed Q3 Provides Further Support For Our Neutral Stance

Nov 11, 2025, 9:17 AM EST - 23 days ago

Solventum: A Mixed Q3 Provides Further Support For Our Neutral Stance

Solventum Corporation (SOLV) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 7:26 PM EST - 4 weeks ago

Solventum Corporation (SOLV) Q3 2025 Earnings Call Transcript

Solventum Reports Third Quarter 2025 Financial Results

Nov 6, 2025, 4:05 PM EST - 4 weeks ago

Solventum Reports Third Quarter 2025 Financial Results

Solventum to Participate in the 2025 Stifel Healthcare Conference

Nov 3, 2025, 4:05 PM EST - 4 weeks ago

Solventum to Participate in the 2025 Stifel Healthcare Conference

Solventum: A Solid Performance Here

Oct 22, 2025, 12:42 PM EDT - 6 weeks ago

Solventum: A Solid Performance Here

Solventum Appoints Heather Knight as Chief Commercial Officer

Oct 21, 2025, 5:00 PM EDT - 6 weeks ago

Solventum Appoints Heather Knight as Chief Commercial Officer

Solventum to Report Third Quarter Fiscal 2025 Earnings on November 6, 2025

Oct 16, 2025, 4:05 PM EDT - 7 weeks ago

Solventum to Report Third Quarter Fiscal 2025 Earnings on November 6, 2025

Solventum Corporation (SOLV) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Sep 9, 2025, 2:03 PM EDT - 3 months ago

Solventum Corporation (SOLV) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Solventum Announces Pricing of its Upsized $2 Billion Note Tender Offers

Sep 8, 2025, 2:30 PM EDT - 3 months ago

Solventum Announces Pricing of its Upsized $2 Billion Note Tender Offers

Solventum Announces Early Tender Results and Upsizing of its Note Tender Offers

Sep 8, 2025, 8:30 AM EDT - 3 months ago

Solventum Announces Early Tender Results and Upsizing of its Note Tender Offers

Solventum Corporation (SOLV) Presents At 2025 Wells Fargo Healthcare Conference (Transcript)

Sep 5, 2025, 1:27 PM EDT - 3 months ago

Solventum Corporation (SOLV) Presents At 2025 Wells Fargo Healthcare Conference (Transcript)

Solventum Completes Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc.

Sep 2, 2025, 8:00 AM EDT - 3 months ago

Solventum Completes Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc.

TMO

Thermo Fisher Scientific Completes Acquisition of Solventum's Purification and Filtration Business

Sep 2, 2025, 8:00 AM EDT - 3 months ago

Thermo Fisher Scientific Completes Acquisition of Solventum's Purification and Filtration Business

TMO

Solventum to Participate in Upcoming Investor Conferences

Aug 28, 2025, 4:05 PM EDT - 3 months ago

Solventum to Participate in Upcoming Investor Conferences

Solventum Announces $1.75 Billion Note Tender Offers

Aug 22, 2025, 8:19 AM EDT - 3 months ago

Solventum Announces $1.75 Billion Note Tender Offers

Solventum Announces Pricing of Secondary Offering of Common Stock

Aug 13, 2025, 10:39 PM EDT - 4 months ago

Solventum Announces Pricing of Secondary Offering of Common Stock

Solventum Announces Launch of Secondary Offering of Common Stock

Aug 13, 2025, 4:48 PM EDT - 4 months ago

Solventum Announces Launch of Secondary Offering of Common Stock

Solventum Corporation (SOLV) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 6:53 AM EDT - 4 months ago

Solventum Corporation (SOLV) Q2 2025 Earnings Call Transcript

Solventum (SOLV) Fiscal Q2 EPS Jumps 8%

Aug 7, 2025, 6:21 PM EDT - 4 months ago

Solventum (SOLV) Fiscal Q2 EPS Jumps 8%

Solventum raises annual profit forecast on strength in surgical equipment

Aug 7, 2025, 4:52 PM EDT - 4 months ago

Solventum raises annual profit forecast on strength in surgical equipment

Solventum Reports Second Quarter 2025 Financial Results

Aug 7, 2025, 4:05 PM EDT - 4 months ago

Solventum Reports Second Quarter 2025 Financial Results

Solventum: Appealing Again

Jul 22, 2025, 9:12 AM EDT - 4 months ago

Solventum: Appealing Again

Solventum to Report Second Quarter Fiscal 2025 Earnings on August 7, 2025

Jul 17, 2025, 4:05 PM EDT - 5 months ago

Solventum to Report Second Quarter Fiscal 2025 Earnings on August 7, 2025

Solventum Named a Best Company to Work for by U.S. News & World Report

Jun 18, 2025, 10:00 AM EDT - 6 months ago

Solventum Named a Best Company to Work for by U.S. News & World Report

Solventum to Participate in the 2025 Goldman Sachs Health Care Conference

Jun 3, 2025, 4:05 PM EDT - 6 months ago

Solventum to Participate in the 2025 Goldman Sachs Health Care Conference

Solventum Corporation (SOLV) Q1 2025 Earnings Call Transcript

May 11, 2025, 5:07 PM EDT - 7 months ago

Solventum Corporation (SOLV) Q1 2025 Earnings Call Transcript

Solventum Corporation: Cheap, With Caveats

May 9, 2025, 11:02 AM EDT - 7 months ago

Solventum Corporation: Cheap, With Caveats

Solventum beats first-quarter profit estimates on strong surgical product sales

May 8, 2025, 6:11 PM EDT - 7 months ago

Solventum beats first-quarter profit estimates on strong surgical product sales

Solventum to Participate in the 2025 BofA Securities Health Care Conference

May 8, 2025, 4:05 PM EDT - 7 months ago

Solventum to Participate in the 2025 BofA Securities Health Care Conference

Solventum Reports First Quarter 2025 Financial Results

May 8, 2025, 4:05 PM EDT - 7 months ago

Solventum Reports First Quarter 2025 Financial Results

Solventum to Report First Quarter Fiscal 2025 Earnings on May 8, 2025

Apr 17, 2025, 4:05 PM EDT - 8 months ago

Solventum to Report First Quarter Fiscal 2025 Earnings on May 8, 2025

Solventum partners with SprintRay to disrupt the digital dentistry market with high-quality, permanent same-day restorations

Mar 25, 2025, 6:00 PM EDT - 9 months ago

Solventum partners with SprintRay to disrupt the digital dentistry market with high-quality, permanent same-day restorations

3M Spin Off Solventum Targets Higher Margins, EPS Growth In 2025-2028 Strategy

Mar 21, 2025, 12:44 PM EDT - 9 months ago

3M Spin Off Solventum Targets Higher Margins, EPS Growth In 2025-2028 Strategy

Solventum to Present Value Creation Formula and Long-Range Plan at 2025 Investor Day

Mar 20, 2025, 9:00 AM EDT - 9 months ago

Solventum to Present Value Creation Formula and Long-Range Plan at 2025 Investor Day

Solventum Launches Attest™ eBowie-Dick Test System Revolutionizing Sterilization Assurance

Mar 12, 2025, 8:12 AM EDT - 9 months ago

Solventum Launches Attest™ eBowie-Dick Test System Revolutionizing Sterilization Assurance

Solventum: Q4 EPS Beats, Cash Flow Dips

Feb 28, 2025, 9:07 AM EST - 9 months ago

Solventum: Q4 EPS Beats, Cash Flow Dips

Solventum Corporation (SOLV) Q4 2024 Earnings Call Transcript

Feb 28, 2025, 8:36 AM EST - 9 months ago

Solventum Corporation (SOLV) Q4 2024 Earnings Call Transcript

Solventum forecasts annual profit above estimates on strong surgical product sales

Feb 27, 2025, 5:09 PM EST - 10 months ago

Solventum forecasts annual profit above estimates on strong surgical product sales

Solventum Reports Fourth Quarter 2024 Financial Results and Introduces 2025 Full-Year Guidance

Feb 27, 2025, 4:05 PM EST - 10 months ago

Solventum Reports Fourth Quarter 2024 Financial Results and Introduces 2025 Full-Year Guidance

Solventum to Host Investor Day on Thursday, March 20, 2025, in New York City

Feb 26, 2025, 4:15 PM EST - 10 months ago

Solventum to Host Investor Day on Thursday, March 20, 2025, in New York City

Nelson Peltz's Trian to push Solventum to further simplify business, WSJ reports

Feb 26, 2025, 3:37 PM EST - 10 months ago

Nelson Peltz's Trian to push Solventum to further simplify business, WSJ reports

Trian Comments on Solventum's Sale of its Purification & Filtration Business

Feb 26, 2025, 2:50 PM EST - 10 months ago

Trian Comments on Solventum's Sale of its Purification & Filtration Business

TMO

Solventum In The Early Stages Of A Multiyear Turnaround Effort

Feb 25, 2025, 10:16 AM EST - 10 months ago

Solventum In The Early Stages Of A Multiyear Turnaround Effort

Thermo Fisher buys Solventum's purification and filtration business for $4.1 billion

Feb 25, 2025, 8:56 AM EST - 10 months ago

Thermo Fisher buys Solventum's purification and filtration business for $4.1 billion

TMO

Solventum Announces Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc. for $4.1B

Feb 25, 2025, 8:39 AM EST - 10 months ago

Solventum Announces Sale of its Purification & Filtration Business to Thermo Fisher Scientific Inc. for $4.1B

TMO

Iightning
Iightning Dec. 5 at 1:59 AM
1ightning® Premium Options Alert (Actionable) Ticker: $SOLV Contract: Dec 19 $85C Entry: 2.08 Exit: 2.78 Return: +34.17% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
Iightning
Iightning Dec. 4 at 8:31 PM
1ightning® Premium Options Alert (Actionable) Ticker: $SOLV Contract: Dec 19 $85C Entry: 2.08 Exit: 2.78 Return: +34.17% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
AtomicAIerts
AtomicAIerts Dec. 4 at 5:05 PM
$SOLV AtomicAlerts® Scalp Alert Direction: SHORT Entry: $85.06 TP1: $84.36 | TP2: $83.66 | TP3: $82.96 Stop Loss: $85.66 EMA9: 85.15 | EMA21: 85.17 RSI14: 43.24 | VWAP: 85.18 Paid Alerts: https://atomicalerts.com
0 · Reply
AtomicAIerts
AtomicAIerts Dec. 4 at 3:31 PM
$SOLV AtomicAlerts® Scalp Alert Direction: LONG Entry: $85.19 TP1: $85.89 | TP2: $86.59 | TP3: $87.29 Stop Loss: $84.59 EMA9: 85.18 | EMA21: 85.12 RSI14: 54.19 | VWAP: 85.17 Paid Alerts: https://atomicalerts.com
0 · Reply
AtomicAIerts
AtomicAIerts Dec. 4 at 1:54 PM
$SOLV AtomicAlerts® Scalp Alert Direction: SHORT Entry: $85.25 TP1: $84.55 | TP2: $83.85 | TP3: $83.15 Stop Loss: $85.85 EMA9: 85.25 | EMA21: 85.23 RSI14: 47.06 | VWAP: 85.92 Paid Alerts: https://atomicalerts.com
0 · Reply
AtomicAIerts
AtomicAIerts Dec. 4 at 12:20 PM
$SOLV AtomicAlerts® Scalp Alert Direction: SHORT Entry: $85.25 TP1: $84.55 | TP2: $83.85 | TP3: $83.15 Stop Loss: $85.85 EMA9: 85.25 | EMA21: 85.23 RSI14: 47.06 | VWAP: 85.92 Paid Alerts: https://atomicalerts.com
0 · Reply
Iightning
Iightning Dec. 4 at 4:14 AM
1ightning® Premium Options Alert (Actionable) Ticker: $SOLV Contract: Dec 19 $85C Entry: 1.97 Exit: 2.53 Return: +28.29% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
BillionerOfKing
BillionerOfKing Dec. 3 at 3:40 PM
$SOLV Current Stock Price: $85.26 Contracts to trade: $85 SOLV Dec 19 2025 Call Entry: $2.00 Exit: $3.57 ROI: 79% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Iightning
Iightning Dec. 3 at 8:45 AM
1ightning® Premium Options Alert (Actionable) Ticker: $SOLV Contract: Dec 19 $50C Entry: 24.25 Exit: 34.70 Return: +43.11% ROI Unlock VIP Access → https://1ightning.com
0 · Reply
JarvisFlow
JarvisFlow Dec. 2 at 11:05 AM
BTIG has adjusted their stance on Solventum ( $SOLV ), setting the rating to Buy with a target price of 100.
0 · Reply
Iightning
Iightning Dec. 1 at 10:26 PM
**1ightning® Premium Options Alert (Actionable)** **Ticker:** $SOLV **Contract:** Dec 19 $90C **Entry:** 0.49 **Exit:** 0.59 **Return:** **+21.33% ROI** This is the level of accuracy our VIP desk delivers daily. If you want **institutional-grade scalps without the noise**, join us. **Unlock VIP Access → https://1ightning.com**
0 · Reply
StockBraker
StockBraker Nov. 28 at 2:07 PM
$SOLV Will buy if it dips to $70 or below.
1 · Reply
MACTEP
MACTEP Nov. 27 at 10:28 AM
$SOLV Doomed. Next target - $75
0 · Reply
Iightning
Iightning Nov. 26 at 1:12 AM
1ightning® Options Trade Alert (Actionable) | Buy $SOLV Dec 19 $85 Call | Enter: $1.70 Exit: $2.84 | Profit: 67.34% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 25 at 11:19 AM
1ightning® Options Trade Alert (Actionable) | Buy $SOLV Dec 19 $85 Call | Enter: $1.70 Exit: $2.84 | Profit: 67.34% ROI | https://1ightning.com
0 · Reply
Iightning
Iightning Nov. 25 at 12:14 AM
1ightning® Options Trade Alert (Actionable) | Buy $SOLV Dec 19 $85 Call | Enter: $1.70 Exit: $2.84 | Profit: 67.34% ROI | https://1ightning.com
0 · Reply
danaos
danaos Nov. 23 at 11:01 PM
$SOLV Overweight
0 · Reply
ja1234567
ja1234567 Nov. 22 at 3:52 AM
$SOLV quite possibly the stupidest move I have seen in 5 years for any biotech company. Is the a word for overpaid to the point of insanity.
1 · Reply
Iightning
Iightning Nov. 21 at 9:32 PM
1ightning® Options Trade Alert (Actionable) | Buy $SOLV Dec 19 $80 Call | Enter: $1.33 Exit: $2.57 | Profit: 94.17% ROI | https://1ightning.com
0 · Reply
Boston7452
Boston7452 Nov. 21 at 8:41 PM
$SINT Theres been a scam or really a con going on here but not what youre implying. Tech is game changing and current mgmt is in process of commercializing it. $ZBH $SOLV ?
0 · Reply
prismmarketview
prismmarketview Nov. 21 at 2:40 PM
(NYSE: $SOLV) #solventum is buying #acerasurgical for $850M, adding the fast-growing Restrata synthetic wound-care platform to its portfolio and strengthening its position in the $900M acute regenerative tissue market. https://prismmarketview.com/solventum-expands-advanced-wound-care-portfolio-with-850-million-acquisition-of-acera-surgical/
0 · Reply
Iightning
Iightning Nov. 21 at 12:34 AM
1ightning® Options Trade Alert (Actionable) | Buy $SOLV Dec 19 $80 Call | Enter: $1.33 Exit: $2.57 | Profit: 94.17% ROI | https://1ightning.com
0 · Reply